Biology STAT+: Lilly says ‘triple-G’ drug beat Novo’s Ozempic in diabetes study STAT News · 28 October 2026 at 11:45 · 1 min read Data add to expectations that the drug will be one of Lilly’s greatest growth drivers. Read in Synapse Read on statnews.com